Home Cart Sign in  
Chemical Structure| 487-39-8 Chemical Structure| 487-39-8

Structure of Phillygenin
CAS No.: 487-39-8

Chemical Structure| 487-39-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Phillygenin is an active ingredient from Forsythia with many medicinal properties, such as antioxidant, reducing blood lipid, inhibition of low density lipoprotein oxidation .

Synonyms: (+)-Phillygenin; Epipinoresinol methyl ether; Sylvatesmin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Dong, Xueming ; Mayes, Heather B. ; Morreel, Kris ; Katahira, Rui ; Li, Yanding ; Ralph, John , et al.

Abstract: Lignin is the largest source of bio-based aromatic compounds in nature, and its valorization is essential to the sustainability of lignocellulosic biorefining. Characterizing lignin-derived compounds remains challenging due to the heterogeneity of this biopolymer. Tandem mass spectrometry is a promising tool for lignin structural analytics, as fragmentation patterns of model compounds can be extrapolated to identify characteristic moieties in complex samples. This work extended previous resonance excitation-type collision-induced dissociation (CID) methods that identified lignin oligomers containing β-O-4, β-5, and β-β bonds, to also identify characteristics of 5-5, β-1, and 4-O-5 dimers, enabled by quadrupole time-of-flight (QTOF) CID with energy-resolved mass spectrometry (ERMS). Overall, QTOF-ERMS offers in-depth structural information and could ultimately contribute to tools for high-throughput lignin dimer identification.

Keywords: analytical methods ; biomass ; fragmentation mechanisms ; mass spectrometry ; renewable resources

Purchased from AmBeed: ;

Alternative Products

Product Details of Phillygenin

CAS No. :487-39-8
Formula : C21H24O6
M.W : 372.41
SMILES Code : OC1=CC=C([C@H]2OC[C@@]3([H])[C@]2([H])CO[C@H]3C4=CC=C(OC)C(OC)=C4)C=C1OC
Synonyms :
(+)-Phillygenin; Epipinoresinol methyl ether; Sylvatesmin
MDL No. :MFCD01075148
InChI Key :CPJKKWDCUOOTEW-YJPXFSGGSA-N
Pubchem ID :3083590

Safety of Phillygenin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Rat cerebrocortical nerve terminals (synaptosomes) 5-30 µM 10 minutes Phillygenin suppressed 4-AP-induced glutamate release in a concentration-dependent manner with an IC50 value of 17 µM. Biomedicines. 2024 Feb 22;12(3):495
HEK 293T cells 20 and 40 µM 24 hours PHI significantly promoted TGR5 activation (Fig. 7H) and elevated intracellular cAMP levels in HEK 293T cells (Fig. 7I). J Pharm Anal. 2025 Jan;15(1):101042
NCM460 cells 20 and 40 µM 24 hours PHI treatment enhanced the expression of tight junction proteins (ZO-1, E-cadherin, and occludin) and suppressed fibrosis markers (N-cadherin, α-SMA, and MMP9) and apoptosis marker (cleaved caspase-3). J Pharm Anal. 2025 Jan;15(1):101042
VSC4.1 cells 0, 25, 50, 100 μg/mL 24 hours To evaluate the effect of PHI on VSC4.1 neuronal cell apoptosis. Results showed that PHI pretreatment partially mitigated the morphological changes induced by LPS-activated microglia and significantly increased the expression of Bcl-xL protein. J Orthop Translat. 2024 Aug 8;48:133-145
BV2 cells 0, 12.5, 25, 50, 100, 200, 400 μg/mL 24 hours To evaluate the effect of PHI on BV2 cell viability. Results showed that PHI did not exert significant toxic effects on microglia at concentrations below 100 μg/mL. J Orthop Translat. 2024 Aug 8;48:133-145
Primary murine chondrocytes 5, 10, 20, 40 µM 24 hours To evaluate the effect of PHI on IL-1β-induced inflammation and ECM degradation. Results showed PHI dose-dependently suppressed pro-inflammatory cytokines (iNOS, COX-2, IL-6, TNF-α) and reduced ECM degradation (inhibited MMP-13 and ADAMTS5, increased Collagen II and Aggrecan). J Orthop Translat. 2023 May 4;41:1-11
Gastric cancer cell BGC823 100 µg/ml 24 hours Evaluate the toxicity of Phillygenin on gastric cancer cells Front Microbiol. 2022 Apr 28;13:863624
Gastric epithelial cell (GES)-1 100 µg/ml 24 hours Evaluate the toxicity of Phillygenin on gastric epithelial cells Front Microbiol. 2022 Apr 28;13:863624
BGC823 100 μg/mL 24 hours To detect the cytotoxicity of PHI-Der on BGC823 cells, results showed survival rates above 90% at 100 μg/mL concentration. Front Microbiol. 2023 May 19;14:1071603
GES-1 100 μg/mL 24 hours To detect the cytotoxicity of PHI-Der on GES-1 cells, results showed survival rates above 90% at 100 μg/mL concentration. Front Microbiol. 2023 May 19;14:1071603
BEAS-2B cells 12.5, 25 and 50 µg/ml 24 hours To evaluate the effect of PHI on LPS-induced inflammation and apoptosis in BEAS-2B cells. Results showed that PHI treatment suppressed LPS-induced inflammation and apoptosis. Mol Med Rep. 2021 Nov;24(5):775
Rat hepatocytes 193.0 ± 47.6 µM 8 hours Inhibited IL-1β-induced NO production and reduced iNOS mRNA and proinflammatory gene (e.g., Tnf and Il1r1) mRNA levels Molecules. 2025 Jan 19;30(2):416

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice Carbon tetrachloride-induced liver fibrosis model Intragastric administration 10, 20, 40 mg/kg Once daily for 4 weeks Improved liver histopathological injury, abnormal liver function, collagen deposition, inflammation and fibrosis Front Pharmacol. 2021 Sep 21;12:756924
SD rats Normal healthy rats Oral 100 mg/kg Single dose To evaluate the oral bioavailability of PG-SMEDDS, the results showed that PG-SMEDDS significantly improved the absorption and bioavailability of PG (relative bioavailability was 587.77%). Pharmaceutics. 2020 Feb 3;12(2):130
C57BL/6 mice DMM-induced osteoarthritis model Intragastric administration 20 mg/kg/d Once daily for 8 weeks To assess the protective effect of PHI on OA progression in DMM model. Results demonstrated PHI significantly improved cartilage erosion and proteoglycan loss, reduced OARSI scores, and alleviated OA progression via activating Nrf2 and inhibiting NF-κB pathway. J Orthop Translat. 2023 May 4;41:1-11
C57BL/6J mice DSS-induced chronic colitis Oral 25, 50, and 100 mg/kg Once daily for 30 days PHI treatment significantly alleviated the symptoms of chronic colitis in mice, including body weight loss, disease activity index scores, colon shortening, splenomegaly, oxidative stress, and inflammatory response. PHI treatment also ameliorated the reduction of tight junction proteins, fibrosis, apoptosis, and intestinal stem cell activity. J Pharm Anal. 2025 Jan;15(1):101042
C57BL/6 mice Acute gastritis mouse model Intragastric administration 28 mg/kg and 7 mg/kg Once a day for 3 consecutive days Evaluate the antibacterial effect of Phillygenin in vivo Front Microbiol. 2022 Apr 28;13:863624
C57BL/6 mice Acute gastritis model Oral 28 mg/kg and 7 mg/kg Once daily for 3 consecutive days To evaluate the in vivo therapeutic effect of PHI-Der on H. pylori infection, results showed that PHI-Der significantly inhibited the colonization of H. pylori, reduced the inflammatory response, and promoted the repair of inflammatory damage. Front Microbiol. 2023 May 19;14:1071603
Sprague-Dawley rats Severe acute pancreatitis (SAP) model Intraperitoneal injection 30 mg/kg Single dose, lasting 12 hours To investigate the mechanism by which PHI rescues impaired autophagy flux by modulating the PI3K/Akt/mTOR signaling pathway in SAP rats. Results showed reduced serum amylase and lipase levels, decreased pancreatic pathology scores, and improved autophagy-related protein expression after PHI intervention. Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241309260
Sprague Dawley rats Spinal cord injury model Intraperitoneal injection 50 mg/kg Immediately after injury, continued for 7 days To evaluate the effect of PHI on inflammatory response, neuronal apoptosis, axonal regeneration, and motor function recovery after spinal cord injury. Results showed that PHI significantly inhibited the inflammatory response and neuronal apoptosis, promoted axonal regeneration, and improved motor function recovery. J Orthop Translat. 2024 Aug 8;48:133-145
C57BL/6 mice DSS-induced acute ulcerative colitis Oral 60 and 20 mg/kg Throughout the whole experiment PHI was able to maintain body weight, reduce DAI and mortality, restore the intestinal mucosal barrier, and inhibit cytokine secretion. PHI reduces macrophage infiltration into colon tissue. Immun Inflamm Dis. 2023 Nov;11(11):e1069

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.69mL

0.54mL

0.27mL

13.43mL

2.69mL

1.34mL

26.85mL

5.37mL

2.69mL

References

 

Historical Records

Categories